About us

Based in beautiful Turin, the first capital city of Italy, diXit is a solutions company focused on building efficient medical applications and services.

We were born as a spin-off of the University of Torino and the Italian National Institute of Nuclear Physics (INFN) and were supported by the 2i3T Incubator in Turin, Italy.

In 2007, we started laying down the foundations of the company following the input of medical researchers who were setting up a multicenter Clinical Trial based on the use of PET/CT for the assessment of the therapy response in Hodgkin Lymphoma. The first beta version of WIDEN was available for testing in 2008 and was used by 3 PET-based Clinical Trials for handling the imaging and diagnosis-related workflow.

Following the success of the beta version, diXit was founded at the beginning of 2011. From then we have worked with public and private organizations worldwide to improve healthcare thanks to science and technology.

50+

Trials

260+

Sites in 26 countries

10k+

Patients

30k+

Imaging studies
Our core expertise is on imaging-based clinical trials with central review system.
Our solutions work smoothly with all kinds of imaging-based studies.

The team

Our multi-disciplinary team is composed of leading experts and PhDs in the fields of oncology & haematology, medical physics, experimental physics, statistics, business development, brand building and management.

Card image

Alexandru Stancu

Card image

Piergiorgio Cerello

Card image

Stephane Chauvie

Advisors

Card image

Andrea Gallamini

Card image

Francesco Crivellari

We featured in 4 publications and appeared in 15 papers with trials results

WIDEN: A tool for medical image management in multicenter clinical trials
Strategies to Homogenize PET/CT Metrics
Automatic Liver Detection and Standardized Uptake Value Evaluation
68Ge phantom-based FDG-PET site qualification program for clinical trials

What our customers say

 +39 3899454479

contact@dixitsolutions.com

  Via Agostino da Montefeltro 2
10134 Torino, Italy

2020–2024 diXit s.r.l. · P.IVA 10493140015 · REA TO 1137723 · All rights reserved.

   

Alexandru Stancu

Alex is an electronics engineer turned web programmer. After finishing his Ph.D. at the University of Turin, he started working on several web development projects that in 2011 turned into diXit, where he has been the head developer of WIDEN ever since it was conceived.

Piergiorgio Cerello

Piergiorgio is one of the founders of the ALICE project at the CERN LHC (Geneva, Switzerland) and one of the developers of its successful computing model, based on the use of GRIDs for the analysis of large quantities of distributed data. In 2001 he proposed to adopt a similar approach for the analysis of medical images. Since then he developed algorithms based on virtual ant colonies for the detection of micro-calcifications and masses in mammograms and lung nodules in chest CTs.

Piergiorgio holds a Ph.D. in Experimental Physics and a BS in Viticulture and Enology from the University of Torino. Senior researcher at the Italian National Institute of Nuclear Physics (INFN), he is co-founder of diXit and, also, a winemaker.

Stephane Chauvie

Stephane has been involved for years in the development of tools and protocols that are a WIDEN core functionality, for the use of PET as a quantitative method, both in the absolute myocardial blood flow quantification and in the therapy response assessment in lymphoma. As a member of the GEANT4 development team at CERN, he contributed to radiobiology projects with the European Space Agency and to the simulation and clinical implementation of IMRT.

Stephane holds a Ph.D. in Medical Physics from the University of Torino. Currently head of the Medical Physics Unit at Santa Croce e Carle Hospital in Cuneo, he is co-founder of diXit

Andrea Gallamini

Associated professor of the Lacassagne Cancer Center in Nice (2013). Responsible for the Imaging committee (2011) of the Italian Lymphoma Foundation (FIL). Member of the European (EHA) and American (ASH) Hematology Association. Member of the Editorial Board of Leukemia and Lymphoma

Francesco Crivellari

Founder and CEO of Oak-V (a ventures builder), Francesco is expert in brand building, business development, management and entrepreneurship. Since 2012 he is a Brand Manager at Procter & Gamble. Previously Entrepreneur in Residence at Rocket Internet Zalora South-East-Asia and then director of operations for Nova Founders Capital GlassesOnline Malaysia. Holds a double-degree in Business Management from Bocconi University and CEMS at HEC Paris